Get the Stockscreener App
2.26
2.80%
-0.065
After Hours:
2.19
-0.07
-3.10%
Cdt Equity Inc stock is traded at $2.26, with a volume of 22,274.
It is down -2.80% in the last 24 hours and down -55.69% over the past month.
CDT Equity Inc is a data-driven biopharmaceutical development company focused on identifying, enhancing, and advancing high-potential therapeutic assets through scientific innovation and strategic partnerships. It has evolved into a broader, more agile platform that leverages artificial intelligence, solid-form chemistry, and efficient asset repositioning to accelerate the development of novel treatments. The company's pipeline includes candidates that target autoimmune disorders, as well as idiopathic male infertility, oncology, dermatology, rare disease and animal health. It has one operating segment focused on the research and development of clinical assets.
See More
Previous Close:
$2.325
Open:
$2.295
24h Volume:
22,274
Relative Volume:
0.28
Market Cap:
$10.98M
Revenue:
-
Net Income/Loss:
$-39.62M
P/E Ratio:
-0.00137
EPS:
-1654.3275
Net Cash Flow:
$-17.96M
1W Performance:
-17.82%
1M Performance:
-55.69%
6M Performance:
-96.82%
1Y Performance:
-99.87%
1-Day Range:
$2.20
$2.38
1-Week Range:
$2.20
$2.83
52-Week Range:
$2.20
$1,709.10
Cdt Equity Inc Stock (CDT) Company Profile
Name
Cdt Equity Inc
Sector
Industry
Phone
(646) 491 9132
Address
4851 TAMIAMI TRAIL NORTH, NAPLES
Compare CDT vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CDT
Cdt Equity Inc
|
2.26 | 11.30M | 0 | -39.62M | -17.96M | -1,654.33 |
VRTX
Vertex Pharmaceuticals Inc
|
423.92 | 108.71B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
701.42 | 74.13B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
783.50 | 48.61B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
296.11 | 41.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
293.86 | 32.81B | 5.36B | 287.73M | 924.18M | 2.5229 |
Cdt Equity Inc Stock (CDT) Latest News
5.35M CDT Equity (NASDAQ: CDT) shares registered for resale by selling holders - Stock Titan
CDT Equity (CDT) director discloses 233,585 Common Stock shares on Form 3 - Stock Titan
CDTTW (CDT Warrant) leadership outlines long-term growth priorities as latest quarterly earnings figures remain undisclosed.Viral Momentum Stocks - Newser
CDT Equity Announces Board Changes and New Chairperson - The Globe and Mail
CDT Equity announces reverse stock split - MSN
Board reshuffle at CDT Equity (NASDAQ: CDT) adds Ulrik Olsen, new chairs - Stock Titan
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Conduit to change name to CDT Equity - MSN
Stock List: Research Stocks from Around the World - GuruFocus
Working capital per share of CDT Equity Inc. – FWB:ZK7 - TradingView
EBITDA per share of CDT Equity Inc. – FWB:ZK7 - TradingView
CDT Equityfiles for offering of up to 5.35 million shares of common stockSEC filing - marketscreener.com
CDT Equity (NASDAQ: CDT) registers 5.35M shares; ELOC and Sarborg issuances - Stock Titan
Equity Inc (CDT) Stock: Is It Reasonably Valued (Dips) 2026-04-20Elite Trading Signals - Xã Thanh Hà
CDT Notes Sarborg Publication of PRISM Framework Expanding AI - 富途牛牛
Prospect Capital Securities Ltd Net Worth (2026) - GuruFocus
Prospect Finance Ltd Net Worth (2026) - GuruFocus
Mark Andrew Taylor Net Worth (2026) - GuruFocus
Keep an eye on the top gainers and losers in Thursday's session. - ChartMill
AstraZeneca (AZN) Advances Portfolio with Strategic Update - GuruFocus
CDT Equity expands multi-pathway value creation strategy across pharma, IP - TipRanks
CDT Expands Multi-Pathway Value Creation Strategy Across Pharma, IP and AI-Driven Discovery - The Manila Times
CDT Equity Inc. 2025 Annual Report: Nasdaq Listing, Reverse Stock Splits, and Financial Highlights (CDT, CDTTW) - Minichart
CDT Equity Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
AI-focused CDT Equity (Nasdaq: CDT) warns of going concern risk - Stock Titan
CDT Equity 10-K: Net loss $39.2M; R&D $5.05M, G&A $31.70M - TradingView
What's Going On With CDT Equity Shares On Monday? - Sahm
CDT Equity Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com
Which stocks are experiencing notable movement on Friday? - ChartMill
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
CDT Environmental (NASDAQ: CDTG) director files Form 3 showing no trades or holdings - Stock Titan
CDT Equity Inc. (CDT) stock price, news, quote and history - Yahoo Finance UK
CDT Equity Inc. (CDTTW) Fundamental Analysis - Meyka
CDT PE Ratio & Valuation, Is CDT Overvalued - Intellectia AI
CDT Equity Delays Annual Report Filing - The Globe and Mail
12 Health Care Stocks Moving In Thursday's After-Market SessionBullfrog AI Hldgs (NASDAQ:BFRG), CDT Eq - Benzinga
CDT (NASDAQ: CDT) expands at‑the‑market capacity to $76.1M under AGP pact - Stock Titan
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Morning Market Movers: ELAB, BATL, CSHR, CDT See Big Swings - RTTNews
CDT Equity files for non-timely 10-K with US SEC - marketscreener.com
CDT Equity Files For Non-Timely 10-K With US SEC - TradingView
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
CDT Surges 32% on New Patents, But Will It Hold Above $6? - Bitget
CDT Equity (CDT) notifies late 10-K; expects filing within 15 days - Stock Titan
Which stocks are experiencing notable movement on Tuesday? - ChartMill
Morning Market Movers: APLS, PEPG, CDT, PHR See Big Swings - RTTNews
Discover the top movers in Tuesday's pre-market session. - ChartMill
The market is filled with gapping stocks in Tuesday's session. - ChartMill
CDT Equity (CDT) entities cashlessly exercise all pre-funded warrants - Stock Titan
CDT Equity (CDT) discloses pre-funded warrants from Sarborg deal - Stock Titan
Cdt Equity Inc Stock (CDT) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.45%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):